CARGO Therapeutics (NASDAQ:CRGX – Get Free Report) was downgraded by Jefferies Financial Group from a “buy” rating to a “hold ...

CARGO Therapeutics (NASDAQ:CRGX – Get Free Report) was downgraded by stock analysts at HC Wainwright from a “buy” rating to a “neutral” rating in a research report issued to clients and investors on ...

CARGO Therapeutics (NASDAQ:CRGX – Get Free Report) was downgraded by research analysts at William Blair from an “outperform” ...

Axsome Therapeutics, Inc. , a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, will host a virtual investor event and conference call today at ...

After a nearly $300 million IPO little more than a year ago, a young Peninsula biotech company will discontinue what had been ...

In a report released today, Michael Yee from Jefferies downgraded CARGO Therapeutics, Inc. (CRGX – Research Report) to a Hold, with a price ...

Discover Qartemi, India's innovative CAR-T cell therapy for B-cell Non-Hodgkin Lymphoma, offering personalized and affordable ...

CARGO Therapeutics, Inc.’s CRGX share price has dipped by 74.30%, which has investors questioning if this is right time to buy.

Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR ...

Dr. Jerome Zeldis and Dr. Blythe Sather bring exceptional backgrounds in cell therapy and solid tumorsCAMBRIDGE, Mass., Jan.